Literature DB >> 9724734

The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains.

M W Mosesson1, K R Siebenlist, D A Meh, J S Wall, J F Hainfeld.   

Abstract

Elongated fibrinogen molecules are comprised of two outer "D" domains, each connected through a "coiled-coil" region to the central "E" domain. Fibrin forms following thrombin cleavage in the E domain and then undergoes intermolecular end-to-middle D:E domain associations that result in double-stranded fibrils. Factor XIIIa mediates crosslinking of the C-terminal regions of gamma chains in each D domain (the gammaXL site) by incorporating intermolecular epsilon-(gamma-glutamyl)lysine bonds between amine donor gamma406 lysine of one gamma chain and a glutamine acceptor at gamma398 or gamma399 of another. Several lines of evidence show that crosslinked gamma chains extend "transversely" between the strands of each fibril, but other data suggest instead that crosslinked gamma chains can only traverse end-to-end-aligned D domains within each strand. To examine this issue and determine the location of the gammaXL site in fibrinogen and assembled fibrin fibrils, we incorporated an amine donor, thioacetyl cadaverine, into glutamine acceptor sites in fibrinogen in the presence of XIIIa, and then labeled the thiol with a relatively small (0.8 nm diameter) electron dense gold cluster compound, undecagold monoaminopropyl maleimide (Au11). Fibrinogen was examined by scanning transmission electron microscopy to locate Au11-cadaverine-labeled gamma398/399 D domain sites. Seventy-nine percent of D domain Au11 clusters were situated in middle to proximal positions relative to the end of the molecule, with the remaining Au11 clusters in a distal position. In fibrin fibrils, D domain Au11 clusters were located in middle to proximal positions. These findings show that most C-terminal gamma chains in fibrinogen or fibrin are oriented toward the central domain and indicate that gammaXL sites in fibrils are situated predominantly between strands, suitably aligned for transverse crosslinking.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724734      PMCID: PMC27925          DOI: 10.1073/pnas.95.18.10511

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).

Authors:  H Kanaide; J R Shainoff
Journal:  J Lab Clin Med       Date:  1975-04

2.  Studies on the structural abnormality of fibrinogen Paris I.

Authors:  M W Mosesson; D L Amrani; D Ménaché
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

3.  Fibrinase. I. Purification of substrate and enzyme.

Authors:  A G LOEWY; K DUNATHAN; R KRIEL; H L WOLFINGER
Journal:  J Biol Chem       Date:  1961-10       Impact factor: 5.157

4.  Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives.

Authors:  M W Mosesson; D K Galanakis; J S Finlayson
Journal:  J Biol Chem       Date:  1974-07-25       Impact factor: 5.157

5.  Titration of the acceptor cross-linking sites in fibrin.

Authors:  L Lorand; D Chenoweth; A Gray
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

6.  Human fibrinogen heterogeneities. II. Cross-linking capacity of high solubility catabolic intermediates.

Authors:  J S Finlayson; M W Mosesson; T J Bronzert; J J Pisano
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

7.  Hybrid fibrin: proof of the intermolecular nature of - crosslinking units.

Authors:  R F Doolittle; R Chen; F Lau
Journal:  Biochem Biophys Res Commun       Date:  1971-07-02       Impact factor: 3.575

8.  Cross-linked fibrinogen dimers demonstrate a feature of the molecular packing in fibrin fibers.

Authors:  W E Fowler; H P Erickson; R R Hantgan; J McDonagh; J Hermans
Journal:  Science       Date:  1981-01-16       Impact factor: 47.728

9.  Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction.

Authors:  M Kloczewiak; S Timmons; J Hawiger
Journal:  Thromb Res       Date:  1983-01-15       Impact factor: 3.944

10.  The preparation and properties of human fibrinogen of relatively high solubility.

Authors:  M W Mosesson; S Sherry
Journal:  Biochemistry       Date:  1966-09       Impact factor: 3.162

View more
  3 in total

1.  Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.

Authors:  S N Murthy; J H Wilson; T J Lukas; Y Veklich; J W Weisel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Engineered isopeptide bond stabilized fibrin inspired nanoscale peptide based sealants for efficient blood clotting.

Authors:  Snehasish Ghosh; Sanchita Mukherjee; Chiranjit Dutta; Kasturee Chakraborty; Paramita Gayen; Somnath Jan; Dhananjay Bhattacharyya; Rituparna Sinha Roy
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

3.  Characterization of the human head louse nit sheath reveals proteins with adhesive property that show no resemblance to known proteins.

Authors:  Jeong Kuk Park; Yu Jin Han; Jae Ho Lee; Sang-Woo Joo; Ju Hyeon Kim; Si Hyeock Lee; SangYoun Park
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.